| Indicators | Browse All

Bristol-Myers Squibb Company (BMY)

Healthcare | Drug Manufacturers - General | Princeton, United States | NYSE
56.67 USD -0.91 (-1.580%) ⇩ (Oct. 13, 2026, 4 p.m. EDT)
Short-term:★★⯪☆☆Long-term:★★☆☆☆Dividends:★★★⯪☆
Hot Take ↕ | Oct. 10, 2026, 5:51 a.m. EDT

Bristol-Myers Squibb presents a classic value trap scenario where attractive metrics mask structural weakness. While the 4.22% dividend yield looks generous, the company is currently executing a multi-year decline, having lost over 11% of its value since 2016 with three consecutive years of negative performance ending recently. The balance sheet is fragile, carrying debt-to-equity well over 200%, which limits the ability to fund aggressive growth or sustain the dividend indefinitely without eroding capital. Although recent headlines mention an Nvidia tie-up and FDA filings, these are insufficient to reverse the long-term downtrend or justify a premium valuation given the high PEG ratio. The stock trades at a discount to its 50-day moving average, offering a temporary bounce opportunity, but the fundamental trajectory remains bearish.
Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.033180
AutoARIMA0.036675
AutoETS0.038580
MSTL0.039508

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 55%
H-stat 0.71
Ljung-Box p 0.000
Jarque-Bera p 0.292
Excess Kurtosis -0.86
Attribute Value
Sector Healthcare
Ex Dividend Date 2026-10-01
Last Dividend Date 2026-10-01
Debt to Equity Ratio 201.859
Revenue per Share 24.14
Market Cap 115,760,635,904
Trailing P/E 12.48
Forward P/E 8.55
Beta 0.18
Profit Margins 18.87%
Website https://www.bms.com

As of Oct. 10, 2026, 5:51 a.m. EDT: Speculators are positioning for a range-bound to slightly bullish outcome over the next few months. Call open interest builds significantly at strikes above the current price (65, 68, 69), while put volume concentrates just below the spot price (56, 58, 60). This 'straddle' style positioning suggests traders expect volatility but lack a strong directional conviction for a massive breakout or crash in the immediate term.

Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
1.03% 4.35% 4.73% 4.16%
Dividend History
Date Dividend Yield %
2026-10-02 0.630000 1.030253
2026-07-02 0.630000 1.083778
2026-04-02 0.630000 1.057047
2026-01-02 0.630000 1.178451
2025-10-03 0.620000 1.364136
2025-07-03 0.620000 1.321398
2025-04-04 0.620000 1.121157
2025-01-03 0.620000 1.095987
2024-10-04 0.600000 1.111935
2024-07-05 0.600000 1.512859
2024-04-04 0.600000 1.167315
2024-01-04 0.600000 1.152959
2023-10-05 0.570000 1.010280
2023-07-06 0.570000 0.898487
2023-04-06 0.570000 0.805768
2023-01-05 0.570000 0.792547
2022-10-06 0.540000 0.768793
2022-06-30 0.540000 0.701299
2022-03-31 0.540000 0.739422
2022-01-06 0.540000 0.878334
2021-09-30 0.490000 0.828122
2021-07-01 0.490000 0.736178
2021-03-31 0.490000 0.776176
2020-12-31 0.490000 0.789940
2020-10-01 0.450000 0.752257
2020-07-02 0.450000 0.760906
2020-04-02 0.450000 0.815070
2020-01-02 0.450000 0.710452
2019-10-03 0.410000 0.827447
2019-07-03 0.410000 0.880584
2019-04-04 0.410000 0.878509
2019-01-03 0.410000 0.908688
2018-10-04 0.400000 0.641437
2018-07-05 0.400000 0.714924
2018-04-05 0.400000 0.641952
2018-01-04 0.400000 0.647773
2017-10-05 0.390000 0.611285
2017-07-05 0.390000 0.692103
2017-04-05 0.390000 0.734740
2017-01-04 0.390000 0.659452
2016-10-05 0.380000 0.693557
2016-06-29 0.380000 0.520548
2016-03-30 0.380000 0.598991
2015-12-30 0.380000 0.546605
2015-09-30 0.370000 0.625000
2015-07-01 0.370000 0.546771
2015-04-01 0.370000 0.582127
2014-12-30 0.370000 0.623001
2014-10-01 0.360000 0.712448
2014-07-01 0.360000 0.748130
2014-04-02 0.360000 0.697810
2013-12-31 0.360000 0.677328
2013-10-02 0.350000 0.745792
2013-07-02 0.350000 0.795635
2013-04-03 0.350000 0.852204
2013-01-02 0.350000 1.070009
2012-10-03 0.340000 1.013111
2012-07-03 0.340000 0.973933
2012-04-03 0.340000 1.003838
2012-01-04 0.340000 0.990099
2011-10-06 0.330000 1.016949
2011-06-29 0.330000 1.156272
2011-03-30 0.330000 1.246694
2011-01-05 0.330000 1.266309
2010-09-29 0.320000 1.169163
2010-06-30 0.320000 1.283079
2010-03-30 0.320000 1.195815
2009-12-30 0.320000 1.249512
2009-09-30 0.310000 1.376554
2009-07-01 0.310000 1.531621
2009-04-01 0.310000 1.411015
2008-12-30 0.310000 1.355487
2008-10-01 0.310000 1.491101
2008-07-02 0.310000 1.505585
2008-04-02 0.310000 1.431210
2008-01-02 0.310000 1.186376
2007-10-03 0.280000 0.941493
2007-07-03 0.280000 0.881335
2007-04-03 0.280000 1.016703
2007-01-03 0.280000 1.061410
2006-10-04 0.280000 1.137287
2006-07-05 0.280000 1.110230
2006-04-05 0.280000 1.140994
2006-01-04 0.280000 1.237296
2005-10-05 0.280000 1.208459
2005-06-29 0.280000 1.110670
2005-03-30 0.280000 1.096319
2005-01-05 0.280000 1.129488
2004-09-29 0.280000 1.173512
2004-06-30 0.280000 1.142857
2004-03-31 0.280000 1.155592
2003-12-30 0.280000 0.985222
2003-10-01 0.280000 1.075682
2003-07-01 0.280000 1.030169
2003-04-02 0.280000 1.274465
2002-12-31 0.280000 1.209503
2002-10-02 0.280000 1.210549
2002-07-02 0.280000 1.147541
2002-04-03 0.280000 0.742706
2002-01-02 0.280000 0.550639
2001-10-03 0.275000 0.484581
2001-07-03 0.261739 0.512582
2001-04-04 0.261739 0.485866
2001-01-03 0.261739 0.411600
2000-10-04 0.233185 0.441441
2000-07-05 0.233185 0.415694
2000-04-05 0.233185 0.380213
2000-01-05 0.233185 0.415694
1999-09-29 0.204632 0.328244
1999-06-30 0.205584 0.306655
1999-03-30 0.204632 0.332046
1999-01-06 0.204632 0.327775
1998-09-30 0.185597 0.375452
1998-06-30 0.185597 0.339316
1998-04-01 0.185597 0.367492
1997-12-30 0.185597 0.409719
1997-10-01 0.180838 0.460258
1997-07-01 0.180838 0.468053
1997-04-02 0.180838 0.626805
1996-12-31 0.180838 0.697249
1996-10-02 0.178458 0.769230
1996-07-02 0.178458 0.837988
1996-04-02 0.178458 0.868306
1996-01-03 0.178458 0.894187
1995-10-04 0.176079 0.972087
1995-07-05 0.176079 1.098332
1995-04-03 0.176079 1.188757
1994-12-30 0.176079 1.278620
1994-10-03 0.173699 1.283514
1994-06-27 0.173699 1.358137
1994-03-25 0.173699 1.407226
1994-01-03 0.173699 1.269563
1993-09-27 0.171320 1.257643
1993-06-28 0.171320 1.233406
1993-03-29 0.171320 1.236052
1993-01-04 0.171320 1.084747
1992-09-28 0.164182 1.101799
1992-06-26 0.164182 1.059504
1992-03-30 0.164182 0.881792
1991-12-27 0.164182 0.812963
1991-09-30 0.142767 0.725078
1991-06-28 0.142767 0.771707
1991-04-01 0.142767 0.780490
1990-12-28 0.142767 0.898879
1990-10-01 0.126110 0.872425
1990-06-29 0.126110 0.836289
1990-04-02 0.126110 0.995302
1989-12-29 0.126110 0.946425
1989-09-19 0.118972 1.015227
1989-06-30 0.118972 1.044385
1989-04-03 0.118972 1.063829
1988-12-30 0.118972 1.104971
1988-10-03 0.099937 0.954549
1988-06-27 0.099937 1.056608
1988-03-25 0.099937 0.997037
1988-01-04 0.099937 0.971102
1987-09-28 0.083280 0.682923
1987-06-26 0.083280 0.681261
1987-03-30 0.083280 0.698250
1986-12-26 0.083280 0.823525
1986-09-29 0.065435 0.759935
1986-06-27 0.065435 0.626784
1985-12-27 0.055917 0.714830
1985-09-30 0.055917 0.870372
1985-06-28 0.055917 0.765785
1985-03-29 0.055917 0.817393
1984-12-28 0.047589 0.765553
1984-10-01 0.047589 0.891368
1984-06-29 0.047589 0.853336
1984-04-02 0.047589 0.871937
1983-12-30 0.035692 0.710066
1983-10-03 0.035692 0.699716
1983-07-01 0.035692 0.736204
1983-04-04 0.035692 0.851073
1983-01-03 0.031230 0.783578
1982-10-04 0.031230 0.838318
1982-07-02 0.031230 0.961093
1982-04-02 0.031230 0.923071
1982-01-04 0.027364 0.872051
1981-10-05 0.027364 0.904191
1981-07-06 0.027364 0.963365
1981-05-01 0.023794 0.754704
1981-04-06 0.027364 0.857822
1980-10-06 0.023794 0.848791
1980-06-30 0.023794 1.028920
1980-03-28 0.023794 1.249978
1979-12-28 0.021415 0.966444
1979-10-05 0.021415 1.014085
1979-06-29 0.021415 1.116280
1979-04-02 0.021415 1.054946
1978-12-29 0.018143 0.853135
1978-10-02 0.018143 0.897047
1978-06-30 0.018143 0.850163
1978-03-31 0.018143 1.020907
1977-12-30 0.016359 0.817860
1977-10-03 0.016359 0.782934
1977-06-27 0.016359 0.866160
1977-03-30 0.016359 0.885330
1976-12-29 0.013384 0.655720
1976-09-28 0.013384 0.606044
1976-06-28 0.013384 0.574147
1976-03-29 0.013384 0.611189
1975-12-26 0.013384 0.640552
1975-09-29 0.011897 0.657072
1975-06-27 0.011897 0.591487
1975-03-31 0.011897 0.679393
1974-12-27 0.011302 0.773513
1974-09-30 0.011302 1.164715
1974-06-28 0.011302 0.737841
1974-03-28 0.011302 0.773513
1973-12-28 0.009815 0.727258
1973-10-01 0.009815 0.545444
1973-07-30 0.009815 0.495300
1973-04-30 0.009815 0.514609
1973-01-29 0.008923 0.437961
1972-10-31 0.008923 0.442809
1972-07-26 0.008923 0.470593
Additional Data
dividendYield 4.45
exDividendDate 2026-10-02
trailingAnnualDividendRate 2.51
trailingAnnualDividendYield 0.04359152
lastDividendValue 0.63
lastDividendDate 2026-10-02
dividendDate 2026-11-02

Info Dump

Attribute Value
52 Week Change 0.32033932
Address1 Route 206 & Province Line Road
All Time High 81.44
All Time Low 0.91088
Ask 0.0
Ask Size 200
Audit Risk 4
Average Analyst Rating 2.5 - Buy
Average Daily Volume10 Day 13,750,720
Average Daily Volume3 Month 11,393,144
Average Volume 11,393,144
Average Volume10Days 13,750,720
Beta 0.184
Bid 0.0
Bid Size 600
Board Risk 8
Book Value 10.925
City Princeton
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 3
Country United States
Crypto Tradeable 0
Currency USD
Current Price 56.67
Current Ratio 1.532
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 58.0242
Day Low 56.15
Debt To Equity 201.859
Display Name Bristol-Myers Squibb
Dividend Date 1,793,577,600
Dividend Yield 4.45
Earnings Call Timestamp End 1,793,304,000
Earnings Call Timestamp Start 1,793,304,000
Earnings Growth 1.531
Earnings Quarterly Growth 1.532
Earnings Timestamp 1,793,277,000
Earnings Timestamp End 1,793,277,000
Earnings Timestamp Start 1,793,277,000
Ebitda 18,929,999,872
Ebitda Margins 0.38487
Enterprise To Ebitda 7.911
Enterprise To Revenue 3.044
Enterprise Value 149,746,647,040
Eps Current Year 6.69477
Eps Forward 6.62447
Eps Trailing Twelve Months 4.54
Esg Populated 0
Ex Dividend Date 1,790,899,200
Exchange NYQ
Exchange Data Delayed By 20
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 63.9638
Fifty Day Average Change -7.2938004
Fifty Day Average Change Percent -0.11403013
Fifty Two Week Change Percent 32.03393
Fifty Two Week High 68.64
Fifty Two Week High Change -11.970001
Fifty Two Week High Change Percent -0.17438813
Fifty Two Week Low 42.52
Fifty Two Week Low Change 14.149998
Fifty Two Week Low Change Percent 0.3327845
Fifty Two Week Range 42.52 - 68.64
Financial Currency USD
First Trade Date Milliseconds 76,253,400,000
Five Year Avg Dividend Yield 3.85
Float Shares 2,039,528,021
Forward Eps 6.62447
Forward P E 8.5546465
Free Cashflow 8,114,375,168
Full Exchange Name NYSE
Full Time Employees 32,500
Fullday Change -0.91000366
Fullday Change Percent -1.5804162
Fullday Price 57.35
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,790,812,800
Gross Margins 0.71661
Gross Profits 35,247,001,600
Has Pre Post Market Data 1
Held Percent Insiders 0.00097000005
Held Percent Institutions 0.84902
Implied Shares Outstanding 2,042,714,656
Industry Drug Manufacturers - General
Industry Disp Drug Manufacturers - General
Industry Key drug-manufacturers-general
Ir Website http://www.bms.com/investors/Pages/home.aspx
Is Earnings Date Estimate 0
Language en-US
Last Dividend Date 1,790,899,200
Last Dividend Value 0.63
Last Fiscal Year End 1,767,139,200
Last Split Date 997,142,400
Last Split Factor 1,000,000:951777
Long Business Summary Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Opdualag to treat unresectable or metastatic melanoma; and Camzyos for the treatment of symptomatic obstructive HCM. The company also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu to treat moderate-to-severe plaque psoriasis; Krazati for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for the reduction of risk of stroke/systemic embolism and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug for multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane to treat breast cancer. Further, the company provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC, as well as NSCLC and pancreatic cancer. It sells its products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies. The company has a strategic collaboration with Arcus Biosciences, Inc. to develop a treatment regimen that delivers tumor control in kidney cancer. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.
Long Name Bristol-Myers Squibb Company
Market us_market
Market Cap 115,760,635,904
Market State PRE
Max Age 86,400
Message Board Id finmb_25798
Most Recent Quarter 1,782,777,600
Net Income To Common 9,281,999,872
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 124,912,001,214
Number Of Analyst Opinions 24
Open 57.775
Operating Cashflow 12,782,000,128
Operating Margins 0.34418
Overall Risk 4
Payout Ratio 0.5529
Peg Ratio 16.03
Phone 609 252 4621
Pre Market Change 0.6499977
Pre Market Change Percent 1.1463804
Pre Market Price 57.35
Pre Market Time 1,791,972,597
Previous Close 57.58
Price Eps Current Year 8.464816
Price Hint 2
Price To Book 5.1871853
Price To Sales Trailing12 Months 2.353528
Profit Margins 0.18871
Quick Ratio 1.29
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 2.5
Region US
Regular Market Change -0.910004
Regular Market Change Percent -1.58042
Regular Market Day High 58.0242
Regular Market Day Low 56.15
Regular Market Day Range 56.15 - 58.0242
Regular Market Open 57.775
Regular Market Previous Close 57.58
Regular Market Price 56.67
Regular Market Time 1,791,921,602
Regular Market Volume 16,959,174
Return On Assets 0.10719
Return On Equity 0.46598998
Revenue Growth 0.057
Revenue Per Share 24.14
Sand P52 Week Change 0.17502642
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 2
Shares Outstanding 2,042,714,656
Shares Percent Shares Out 0.0224
Shares Short 45,847,626
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 44,073,318
Short Name Bristol-Myers Squibb Company
Short Percent Of Float 0.0225
Short Ratio 3.99
Source Interval 15
State NJ
Symbol BMY
Target High Price 82.0
Target Low Price 41.0
Target Mean Price 65.625
Target Median Price 65.5
Total Cash 11,066,999,808
Total Cash Per Share 5.418
Total Debt 45,053,001,728
Total Revenue 49,186,000,896
Tradeable 0
Trailing Annual Dividend Rate 2.51
Trailing Annual Dividend Yield 0.04359152
Trailing Eps 4.54
Trailing P E 12.482379
Trailing Peg Ratio 17.0263
Triggerable 1
Two Hundred Day Average 59.5469
Two Hundred Day Average Change -2.8769035
Two Hundred Day Average Change Percent -0.048313238
Type Disp Equity
Volume 16,959,174
Website https://www.bms.com
Zip 8,543